Miyoung Chun is Executive Vice President of Science Programs at The Kavli Foundation.
Dr. Chun’s career spans a wide range of experience in academia and industry. Her academic career began as an Assistant Professor of Biochemistry and a member of Whitaker Cardiovascular Institute at Boston University School of Medicine in 1995. There she taught in the areas of cell biology and molecular medicine, and conducted research in signal transduction of G-protein coupled receptors.
From 1999 to 2004 she worked for Millennium Pharmaceuticals Inc. as a scientist and project leader, where her research focused on genomics/functional genomics and on molecular imaging in drug discovery and development. She discovered and characterized novel genes that are important to inflammatory and cardiovascular diseases, and has over 30 U.S. and International issued/published patents.
In 2004 she moved back to academia as Assistant Dean of Science and Engineering at the University of California, Santa Barbara (UCSB), in particular serving the California Nanosystems Institute. She was also appointed Director of International Research Advancement at UCSB. In this role she was active in building partnerships among academia, government and industry around the globe.
Dr. Chun was Vice President of Science Programs at The Kavli Foundation since 2007 and became Executive Vice President of Science Programs in 2013.
She obtained her Ph.D. degree in Molecular Genetics from The Ohio State University in 1990 and was a Postdoctoral Fellow at MIT’s Whitehead Institute studying the cell and molecular biology of receptors.